| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423707 Nitroimidazole ester analogues and therapeutic applications |
| 07/23/2002 | US6423704 Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| 07/23/2002 | CA2102180C Novel immunosuppressive pyrrolidine/piperidine/azepane-2-carboxylic acid derivatives |
| 07/18/2002 | WO2002055519A2 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 07/18/2002 | WO2002055516A2 1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a) |
| 07/18/2002 | WO2002055514A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 07/18/2002 | WO2002055512A1 Xanthene derivatives |
| 07/18/2002 | WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | WO2002055496A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055491A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
| 07/18/2002 | WO2002055484A1 Biaryl compound, process for producing the same, and agent |
| 07/18/2002 | WO2002055025A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 07/18/2002 | WO2002055014A2 Therapeutic chroman compounds |
| 07/18/2002 | WO2002055013A2 Therapeutic chromone compounds |
| 07/18/2002 | WO2002055012A2 Therapeutic heterocyclic compounds |
| 07/18/2002 | WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 07/18/2002 | WO2002041834A3 Atorvastatin hemi-calcium form vii |
| 07/18/2002 | WO2002040455A8 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) |
| 07/18/2002 | WO2002034699A3 Mammalian metabolites of a tachykinin receptor antagonist |
| 07/18/2002 | WO2002024661A3 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 07/18/2002 | WO2001072728A3 Novel piperazine derivatives |
| 07/18/2002 | WO2001056974A3 Inha inhibitors and their use as antibacterials |
| 07/18/2002 | US20020095033 Monocyclic L-nucleosides, analogs and uses thereof |
| 07/18/2002 | US20020094989 Pyrrolidine modulators of CCR5 chemokine receptor activity |
| 07/18/2002 | US20020094963 Benzimidazole derivatives |
| 07/18/2002 | US20020094568 Apparatus for reducing concentration of low molecular weight compounds in biological composition |
| 07/18/2002 | CA2538995A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 07/18/2002 | CA2434274A1 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | CA2434205A1 1,1-disubstituted cyclic inhibitors of matrix metalloprotease and tnf-.alpha. |
| 07/18/2002 | CA2434152A1 Therapeutic heterocyclic compounds |
| 07/18/2002 | CA2434044A1 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha |
| 07/18/2002 | CA2434015A1 Therapeutic chroman compounds |
| 07/18/2002 | CA2433950A1 Therapeutic chromone compounds |
| 07/18/2002 | CA2433070A1 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 07/17/2002 | EP1223170A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 07/17/2002 | EP1222305A2 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams |
| 07/17/2002 | EP1222182A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 07/17/2002 | EP1222176A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION |
| 07/17/2002 | EP1222174A1 Imidazol-4-ylmethanols used as inhibitors of steroid c17-20 lyase |
| 07/17/2002 | EP1222171A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 07/17/2002 | EP1222170A1 Novel nicotinonitrile compounds |
| 07/17/2002 | EP1222167A2 Method for producing indole derivatives on a solid phase |
| 07/17/2002 | EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 07/17/2002 | EP0851865B1 12H-Dibenzo[d,g][1,3]dioxocine derivatives |
| 07/17/2002 | EP0598061B1 Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 07/17/2002 | CN1359377A Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 07/17/2002 | CN1087741C New indole and inidazole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/16/2002 | US6420975 Interior rearview mirror sound processing system |
| 07/16/2002 | US6420568 Compounds for antifibrillatory and antiarrhythmic agents. the processes of this invention are useful for making |
| 07/16/2002 | US6420563 Inverse antagonist |
| 07/16/2002 | US6420438 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| 07/16/2002 | US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury |
| 07/16/2002 | US6420415 Thiol compounds, their production and use |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420409 Benzimidazole derivatives |
| 07/16/2002 | US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 07/16/2002 | US6420406 Triazolyl disulphides |
| 07/16/2002 | US6420393 Nuclear factor .kappa.b-dependent disease selected from the group consisting of inflammatory diseases, immunological disorders, septic shock, transplant rejection, radiation damage, reperfusion injuries after ischemia, stroke or |
| 07/16/2002 | US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase. |
| 07/16/2002 | US6420390 Heteroarylpiperidines and their use as antipsychotics |
| 07/16/2002 | US6420387 Antitumor |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420376 Amido spiropiperidines promote the release of growth hormone |
| 07/16/2002 | US6420375 Fused ring compounds, process for producing the same and use thereof |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/16/2002 | US6420363 Mono- or polyenic carboxylic acid derivatives |
| 07/16/2002 | US6420316 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/16/2002 | CA2119511C Benzimidazole compounds, their use and preparation |
| 07/11/2002 | WO2002053562A1 Kojic acid derivative and preparation method thereof |
| 07/11/2002 | WO2002053558A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 07/11/2002 | WO2002053557A1 Novel sulfamides and their use as endothelin receptor antagonists |
| 07/11/2002 | WO2002053551A1 Process for preparing optically active 2,3-dihydro- benzofuran compounds |
| 07/11/2002 | WO2002053546A1 Heterocycle derivatives as ppar-gamma agonists |
| 07/11/2002 | WO2002053544A1 Pharmaceutical uses and synthesis of nicotinanilide-n-oxides |
| 07/11/2002 | WO2002053543A1 Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 07/11/2002 | WO2002053155A1 Telomerase inhibitor |
| 07/11/2002 | WO2002018348A3 Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 07/11/2002 | WO2002008221A3 Capsaicin receptor ligands |
| 07/11/2002 | WO2001096311A3 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 07/11/2002 | WO2001040187A3 Compound having effect of promoting neuron differentiation |
| 07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
| 07/11/2002 | US20020091264 Compounds containing dibenzo(A,D)cycloheptene or dibenz(B,F)oxepine derivatives are useful for treating osteoporosis, cardiovascular diosrders, cancer and inflammation |
| 07/11/2002 | US20020091261 Phthalazines with angiogenesis inhibiting activity |
| 07/11/2002 | US20020091260 Selective control of harmful plants in crops of useful plants |
| 07/11/2002 | US20020091148 3-substituted indole antiproliferative angiogenesis inhibitors |
| 07/11/2002 | US20020091147 Substituted-phenyl ketone derivatives as ip antagonists |
| 07/11/2002 | US20020091143 Use of 4-substituted tetrahydropyridines for the manufacture of medicament s acting upon TGF-beta 1 |
| 07/11/2002 | US20020091141 Treating serotonin-related central nervous system disorders |
| 07/11/2002 | US20020091138 Treating vascular proliferative disorders |
| 07/11/2002 | US20020091131 Useful particularly as remedies for bone diseases and arthritis |
| 07/11/2002 | US20020091127 Semicarbazides and their uses |
| 07/11/2002 | US20020091122 Voltage-dependent |
| 07/11/2002 | US20020091120 2-substituted heterocyclic compounds for treating multidrug resistance |
| 07/11/2002 | US20020091116 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/11/2002 | US20020091078 Treating diabetes, especially Type II diabetes |
| 07/11/2002 | CA2433779A1 Heterocycle derivatives as ppar-gamma agonists |
| 07/11/2002 | CA2432410A1 Process for preparing optically active 2,3-dihydro- benzofuran compounds |